Cyclerion Therapeutics (CYCN) Leases (2019 - 2023)
Historic Leases for Cyclerion Therapeutics (CYCN) over the last 5 years, with Q2 2023 value amounting to $1.1 million.
- Cyclerion Therapeutics' Leases fell 1412.21% to $1.1 million in Q2 2023 from the same period last year, while for Jun 2023 it was $1.1 million, marking a year-over-year decrease of 1412.21%. This contributed to the annual value of $1.2 million for FY2022, which is 1312.41% down from last year.
- As of Q2 2023, Cyclerion Therapeutics' Leases stood at $1.1 million, which was down 1412.21% from $1.2 million recorded in Q1 2023.
- In the past 5 years, Cyclerion Therapeutics' Leases registered a high of $70.3 million during Q2 2019, and its lowest value of $1.1 million during Q2 2023.
- In the last 5 years, Cyclerion Therapeutics' Leases had a median value of $6.3 million in 2021 and averaged $26.9 million.
- Examining YoY changes over the last 5 years, Cyclerion Therapeutics' Leases showed a top increase of 1276.74% in 2022 and a maximum decrease of 9680.16% in 2022.
- Cyclerion Therapeutics' Leases (Quarter) stood at $68.1 million in 2019, then crashed by 36.3% to $43.4 million in 2020, then plummeted by 96.77% to $1.4 million in 2021, then fell by 13.12% to $1.2 million in 2022, then decreased by 7.64% to $1.1 million in 2023.
- Its last three reported values are $1.1 million in Q2 2023, $1.2 million for Q1 2023, and $1.2 million during Q4 2022.